National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Am J Trop Med Hyg. 2011 Oct;85(4):674-9. doi: 10.4269/ajtmh.2011.11-0245.
Schistosomiasis continues to be a public health problem in many tropical and subtropical countries. Improving the diagnostic tools for surveillance and monitoring in areas that have reached elimination level will help hasten the possible elimination of this disease. This study therefore aims to develop enzyme-linked immunosorbent assay through the use of recombinant proteins such as thioredoxin peroxidase-1 (SjTPx-1) and four tandem repeat proteins (Sj1TR, Sj2TR, Sj4TR, and Sj7TR). Cutoff values were calculated using 38 serum samples from healthy Japanese volunteers. Sera from 35 schistosomiasis-confirmed patients, four cured from the disease by chemotherapy, and 15 endemic negative controls were used to assess these antigens. SjTPx-1 and Sj7TR both had 85.71% sensitivity. Furthermore, these antigens were also tested against human sera positive for other parasitic infections and showed no or very minimal cross-reaction. These results suggest the potential defined antigens for development of an accurate diagnostic test for schistosomiasis.
血吸虫病在许多热带和亚热带国家仍然是一个公共卫生问题。改进在已达到消除水平的地区进行监测和监控的诊断工具将有助于加速消除这种疾病。因此,本研究旨在通过使用重组蛋白(如硫氧还蛋白过氧化物酶-1(SjTPx-1)和四个串联重复蛋白(Sj1TR、Sj2TR、Sj4TR 和 Sj7TR)来开发酶联免疫吸附测定法。使用来自 38 名健康日本志愿者的 38 份血清样本计算了截断值。使用 35 名经证实患有血吸虫病的患者、4 名经化疗治愈的患者和 15 名地方性阴性对照的血清来评估这些抗原。SjTPx-1 和 Sj7TR 的敏感性均为 85.71%。此外,这些抗原还针对其他寄生虫感染阳性的人类血清进行了测试,结果显示没有或非常轻微的交叉反应。这些结果表明,这些抗原具有成为血吸虫病准确诊断测试的潜力。